🇨🇦 Axitinib (AG-013736) in Canada

Axitinib (AG-013736) (axitinib-ag-013736) regulatory status in Canada.

Marketing authorisation

Axitinib (AG-013736) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Canada

Frequently asked questions

Is Axitinib (AG-013736) approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Axitinib (AG-013736) in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.